medicines optimisation in older people: case … · medicines optimisation in older people: case...
TRANSCRIPT
Medicines Optimisation in Older People:
Case Management
Catherine Leon
GSTT Community Health Services
October 2012
Case Management Pharmacist
Support patients on Community Matron
caseload who are at risk of medicines related
issues
– Optimise Medicines
– Reduce polypharmacy
– Improve adherence
Background
Community Matrons
– Case Managers
– Act as a single point of contact for patients for
care, support and advice for high intensity
patients
– Patients gathered from GP surgery lists using
computer program
– Patients referred by GP surgery
Patients
Patients at high risk of hospital admission
Complex patients, may have:
– Complex medicines, polypharmacy
– Multiple long term conditions
– Frailty, reduced mobility and dexterity
– Reduced vision, impaired hearing
– Deteriorating renal function
– Reduced cognition
– Social issues e.g. isolation, language or literacy problems
Referral to Case Management Pharmacist
Does the patient need help getting a regular supply of their medicines? Access issues
Does the patient always take his/her medicines the way the doctor prescribed them? Non-adherence issues
Can the patient swallow and use all of his/her medicines and get them all out of their containers? Unintentional non-adherence issues
Does the patient think some of his/her medicines could work better? Clinical issues
Prioritising patients
More than 10 medicines/day or 12 doses/day
Drugs with narrow therapeutic index or increased risk in older people (psychotropics, benzodiazepines, NSAIDs, insulin, opiates)
Swallowing difficulty
Falls risk
Known adherence issues
Communication difficulties
Complex devices
Complex regimens (e.g. warfarin, bisphosphonates, PD meds)
Age over 85
Deteriorating or poor renal function
Uses a dosett box
During the visit
Conversation with patient to gather information
Explore all areas of medicine taking
– Patients beliefs regarding medicines
– Access to pharmacy and GP services
– Physical ability to take medicines (insulin, inhalers, screw
caps)
– How patient is taking their medicines
– Patients knowledge of medicines and side effects
– Any other issues patient is experiencing with health or
medicines
Optimising medicines
Clinical review – Blood tests (e.g. TFTs), adherence to guidelines,
control of disease states
Appropriateness of prescribed medicines – E.g. antihypertensives in patient with falls and low
BP
Efficacy of prescribed medicines – E.g. pain control, number of times salbutamol or
GTN required, blood pressure
Reduce Polypharmacy
Ensure all medicines have an indication
Ensure all medicines are needed
Confirm all medicines are suitable for this patient
Trial withdrawal of medicines where appropriate
Monitor changes
– E.g. BP monitoring, blood tests, patient satisfaction
Improve adherence
Explore non-intentional adherence and find
solutions with patient
– E.g. ability to read, swallow, open bottles, use
inhaler devices or insulin pens and testing
equipment
– Try out devices to improve adherence, e.g.
haleraids, spacers, dosett boxes, medicine record
card, large print labels
Improve adherence
Explore reasons for intentional non-
adherence
Provide rationale and teaching behind
prescriptions where appropriate
Develop plan with patient as to how to
proceed
– e.g. alternative agent, different formulation,
different packaging
Following patient visit
Arrange appointment with GP to discuss clinical
issues
Liaise with community pharmacy
Organise any follow up monitoring by DNs, GP
practice or Community Matrons
Liaise with social services where appropriate
Arrange follow up visits with patient if required for
adherence support and monitoring
– E.g. following up dosett boxes and inhalers etc
Benefits to patients
Opportunity to ask questions, learn about medicines,
get assistance where needed
Appropriate medicines
Reduced pill burden
Empowerment and engagement with medicines
Improved health outcomes
– E.g. breathing easier, pain controlled, diabetes control
improved
Prevention of adverse drug reactions
QIPP Benefits
Reduced polypharmacy – Reduced spend on wasted medicines
Positive patient experience
Increasing skills and knowledge of Community Matrons
Increased collaboration between different health professionals e.g. GPs, community pharmacist, district nurses, community matrons, social services, occupational therapy, physiotherapy
?Reduced use of emergency services
?Fewer medicine related admissions
Example Patient
Mrs S
PMH:
– Hypertension
Most recent BP readings: 198/103 and and 180/94mmHg
– Epilepsy
– Low bone mineral density
– Hypothyroidism
– Vertigo
– COPD
Mrs S - Medicines
Amlodipine 10mg OD
Candesartan 32mg OD
Atenolol 100mg/
chlortalidone 25mg OD
Moxonidine 300mg OD
Doxazosin 8mg twice OD
Levothyroxine 75microg OD
Carbamazepine 200mg TDS
Dosuliepin 75mg at night
Peppermint oil capsules
TDS
Betahistine 8mg three times
daily
Adcal D3 2 daily
Seretide 250microg MDI, 2p
BD
Tiotropium 18microg OD
Salbutamol 100microg PRN
Mrs S - Issues
Adherence
– Medicines in MDS
– Brand changes leading to altered tablet
appearance
– Mrs S felt disempowered and did not trust
pharmacy
– Stopped taking altogether
Mrs S - Issues
Clinical
– BP not controlled despite maximum doses of most meds
– Unable to have zolendronic acid infusion due to
uncontrolled high BP
– Moxonidine should not be used in epilepsy and can cause
dizziness
– Salbutamol MDI not compatible with volumatic spacer
– Dosuliepin increases risk of falls
– Needs TFT levels checked again to ensure not over
replacing thyroid hormones
Mrs S - Actions
Medicines in original packs and medicine reminder chart provided
Discussed with consultant at hypertension clinic – In view of poor adherence, all HT medicines stopped except
amlodipine and candesartan
– BP monitored twice weekly
– Agreed with patient to continue co-tenidone
– Adherence monitored by Case Management Pharmacist
Aerochamber supplied to fit with all inhaler devices
Dosuliepin stopped
Patient reduced peppermint oil capsules to PRN
Mrs S - Outcomes
Better control of blood pressure? – Engagement with patient
– Patient feels control of her BP medicines
– Empowered to adhere to therapy
Reduced polypharmacy and waste – Dosuliepin, moxonidine, peppermint oil capsules
all stopped with no ill consequences (had not been taking)
Patient satisfaction
Thank you!
Catherine Leon
Case Management Pharmacist
GSTT Community Health Services